Table 4.
Unadjusted models | Adjusted model a | ||||
---|---|---|---|---|---|
OR | [95% CI] | OR | [95% CI] | ||
Th1-type cytokines b | IL-1β | 1.50 | [0.79, 2.83] | 3.37 | [0.76, 14.84] |
IFN-γ | 1.35 | [0.94, 1.94] | 1.40 | [0.83, 2.37] | |
TNF-α | 1.16 | [0.73, 1.86] | 0.94 | [0.38, 2.34] | |
Th2-type cytokines b | IL-1RA | 1.14 | [0.81, 1.61] | 0.52 | [0.25, 1.08] |
IL-4 | 0.90 | [0.51, 1.58] | 0.97 | [0.42, 2.24] | |
IL-6 | 1.60 | [0.55, 4.61] | 0.94 | [0.11, 8.29] | |
Growth factors b | G-CSF | 0.79 | [0.52, 1.19] | 0.65 | [0.33, 1.26] |
TPO | 1.62 | [1.13, 2.34] | 2.78 | [1.48, 5.22] |
Abbreviations: IL, interleukin; RA, receptor antagonist; G-CSF, granulocyte colony stimulating factor; IFN, interferon; TNF, tumor necrosis factor; TPO, thrombopoietin
Adjusted model included terms for all cytokines, maternal age, and gestational age at sample collection
Biomarkers were standardized by dividing assay-determined concentration by the standard deviation among controls